A phase II trial of monalizumab in combination with durvalumab (MEDI4736) plus platinum-based chemotherapy for first-line treatment of extensive stage small cell lung cancer (MOZART): Hoosier Cancer Research Network LUN21-530 study.

Hirva Mamdani, Shadia I. Jalal, Ryan D. Gentzler et al.|Journal of Clinical Oncology|2024

Cited by 1